Vector BioPharma is a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery, to improve treatments for patients. Incorporating cutting-edge platform technologies, from world-class academic research at the University of Zürich, Vector BioPharma uses engineered adenoviral vectors to achieve cell- and tissue-specific delivery, and tunable expression of genes and regulators with unprecedented precision.

| vectorbiopharma.com